symbol,statement_type,period_end,line_item,value
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,674200000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,-598500000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-776100000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,702400000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-1771600000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,End Cash Position,45800000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,100000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,67400000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-21700000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-821200000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,-133200000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-334400000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-90600000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,-598500000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,-598500000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,335500000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,409200000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-73700000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-776100000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,702400000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-1646300000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,122000000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,100000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,2700000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,2700000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,0.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-1771100000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,500000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-1771600000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,2445800000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-551200000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,35800000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-437300000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,129600000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,343500000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,236700000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,37200000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,557800000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Depreciation,557800000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-3100000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,2500000.0
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,
AARTIDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,2117700000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,1325900000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,-598500000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-459400000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,1481900000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,0.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-2263300000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,End Cash Position,67400000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,75000000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-7600000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-1360300000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,-133200000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-313100000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-92700000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,-598500000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,-598500000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,0.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-222800000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,-1245300000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,1022500000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-459400000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,1481900000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-2236500000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,-100000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,25000000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,0.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,0.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,0.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,0.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-2261400000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,1900000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-2263300000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,3589200000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-624000000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,1027900000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Payable,-925300000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,342500000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,1610700000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,310200000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,19000000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,514500000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,3989000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Depreciation,514500000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,1800000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-18300000.0
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,
AARTIDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,2355300000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-314966000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,0.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-558611000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,1158382000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,7556000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-1648178000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,End Cash Position,75034000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,216120000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-141086000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,165422000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,1000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-361863000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-94013000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,7556000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,0.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,7556000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,613741000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,13970000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,599771000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-558611000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,1158382000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-1639720000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,1000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,6992000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,11000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,0.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,0.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-1646724000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,1454000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-1648178000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,1333212000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-596748000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-1163371000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-277366000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,58218000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-944223000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,354871000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,7594000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,503241000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,648000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Depreciation,502593000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-1123000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-13074000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-1112000.0
AARTIDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,2241821000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-815609000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,-600000000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-68700000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,2028200000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,0.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-1519749000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,End Cash Position,216120000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,88129000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,127992000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,920251000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,-138377000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-205785000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-95077000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,-600000000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,-600000000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,0.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,1959490000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,1959490000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-68700000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,2028200000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-1496399000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,-100000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,7169000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,15981000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,0.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,0.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-1519549000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,200000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-1519749000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,704140000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-833767000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-1873513000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Payable,1171459000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-1106302000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-1938670000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,198616000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,16865000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,500489000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,407000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Depreciation,500082000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-15981000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,12052000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-169000.0
AARTIDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,2699551000.0
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,-1000.0
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,0.0
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,11755000.0
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Depreciation,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
AARTIDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
